ELAB
$4.44
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to add...
Recent News
BC-Most Active Stocks
Nu Holdings Ltd. 57,555,137 13.98
This Week In AI Chips - Reshoring Boosts Manufacturing Amid Strategic Partnerships and Acquisitions
Recent developments in the AI chip industry have underscored the strategic importance of precision manufacturing in supporting critical supply chains. PMGC Holdings Inc. recently completed the acquisition of AGA Precision Systems LLC, a California-based CNC machining company. This acquisition is part of a broader trend towards reshoring and strengthening domestic manufacturing capabilities, particularly for industries like aerospace and defense. As demand for high-tolerance and specialty...
Northstrive announces initiation of Phase II of AI Development Program
Northstrive Biosciences announced the initiation of Phase II of the AI Development Program with strategic partner Yuva Biosciences. As part of the Phase II objective, both companies will collaborate to leverage MitoNova, YuvaBio’s AI mitochondrial science-focused artificial intelligence platform, to compile a selection of small molecule candidates that promote mitochondrial health in obesity and cardiac diseases. YuvaBio will use MitoNova to virtually screen a large-scale library of diverse, dru